Thyroid substitution may be a risk factor for Covid-19
- PMID: 34212315
- PMCID: PMC8248755
- DOI: 10.1007/s12020-021-02791-1
Thyroid substitution may be a risk factor for Covid-19
Conflict of interest statement
The authors declare no competing interests.
Comment in
-
Thyroid hormone treatment and SARS-CoV-2 infection.Endocrine. 2022 Feb;75(2):328-329. doi: 10.1007/s12020-021-02957-x. Epub 2022 Jan 16. Endocrine. 2022. PMID: 35034248 Free PMC article. No abstract available.
References
-
- Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, Feldman J, Muus C, Wadsworth MH, Kazer SW, Hughes TK, Doran B, Gatter GJ, Vukovic M, Taliaferro F, Mead BE, Guo Z, Wang JP, Gras D, Plaisant M, Ansari M, Angelidis I, Adler H, Sucre JMS, Taylor CJ, Lin B, Waghray A, Mitsialis V, Dwyer DF, Buchheit KM, Boyce JA, Barrett NA, Laidlaw TM, Carroll SL, Colonna L, Tkachev V, Peterson CW, Yu A, Zheng HB, Gideon HP, Winchell CG, Lin PL, Bingle CD, Snapper SB, Kropski JA, Theis FJ, Schiller HB, Zaragosi L-E, Barbry P, Leslie A, Kiem H-P, Flynn JL, Fortune SM, Berger B, Finberg RW, Kean LS, Garber M, Schmidt AG, Lingwood D, Shalek AK, Ordovas-Montanes J, HCA Lung Biological Network. Electronic address: lung-network@humancellatlas.org, and HCA Lung Biological Network, Cell. 2020;181:1016. doi: 10.1016/j.cell.2020.04.035. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical